27.81
+0.06(+0.22%)
Currency In USD
| Previous Close | 27.75 |
| Open | 27.66 |
| Day High | 28.96 |
| Day Low | 27.38 |
| 52-Week High | 45.3 |
| 52-Week Low | 25.71 |
| Volume | 1.47M |
| Average Volume | 1.49M |
| Market Cap | 2.56B |
| PE | -21.73 |
| EPS | -1.28 |
| Moving Average 50 Days | 31.17 |
| Moving Average 200 Days | 34.1 |
| Change | 0.06 |
If you invested $1000 in Legend Biotech Corporation (LEGN) since IPO date, it would be worth $751.62 as of December 04, 2025 at a share price of $27.81. Whereas If you bought $1000 worth of Legend Biotech Corporation (LEGN) shares 3 years ago, it would be worth $545.4 as of December 04, 2025 at a share price of $27.81.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade
GlobeNewswire Inc.
Nov 27, 2025 2:00 PM GMT
Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as a global biotech hub SOMERSET, N.J. and GHENT, Belgium, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Lege
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
GlobeNewswire Inc.
Nov 13, 2025 5:08 PM GMT
31,000-square-foot site expands Legend’s U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation The facility will support CAR-T R&D in potential oncology and immunology indications A Media Snippet accompanying
Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results
GlobeNewswire Inc.
Oct 29, 2025 12:00 PM GMT
SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, November 12, 2025, to review third